Abstract:Depression represents a condition characterized by cognitive deficits and neural dysfunction and has recently been correlated with microRNAs (miRs) and their respective target genes. The present study was conducted with the goal of investigating the expression of miR‐192‐5p and its target gene fibulin (Fbln)‐2 in an attempt to evaluate their roles in the occurrence and progression of cognitive impairment and neural function in mice with chronic unpredictable mild stress (CUMS)–induced depression through regulation of the TGF‐β1 signal transduction pathway. Verification of the targeting relationship between miR‐192‐5p and Fbln2 was provided in the form of initial bioinformatics prediction, followed by a further verification in the form of a dual‐luciferase reporter gene assay. Normal mice and models induced by CUMS were assigned into various groups, whereas mimics, inhibitors, and small interfering RNA were introduced to validate the regulatory mechanism by which miR‐192‐5p regulates Fbln2 depression. Novel object recognition, tail suspension testing, and Morris water maze were all employed 28 d after transfection. Hippocampal electrophysiological recordings, Golgi staining, HPLC mass spectrometry, and fluorescence immunohistochemistry were performed to further evaluate cognitive function and neuron regeneration. CUMS‐induced depression was determined to represent a predisposing factor for cognitive impairment and damage to neural function in mice, highlighted by novel object recognition, learning and memory abilities, population spike amplitude, synaptic transmission, cAMP levels, neuronal regeneration, and increased behavioral changes that resemble depression. Furthermore, increased Fbln2 expression, an activated TGF‐βl signaling pathway, and decreased expression of miR‐192‐5p, synaptophysin, brain‐derived neurotrophic factor, N‐methyl‐d‐aspartate receptor subunit 2B, and calmodulin‐dependent protein kinase II were noted. Up‐regulated miR‐192‐5p targeting Fbln2 acts to alleviate CUMS‐induced depression by inhibiting the TGF‐β1 signaling pathway, resulting in the enhanced cognitive function in novel object recognition, learning and memory ability, population spike amplitude, synaptic transmission, neuron regeneration, and alleviation of behavioral symptoms. The central findings of the present study indicate that up‐regulated levels of miR‐192‐5p expression act to suppress activation of the TGF‐β1 signaling pathway by means of binding to Fbln2, thereby ameliorating cognitive impairment and strengthening neural function in a mouse model of depression.—Tang, C.‐Z., Yang, J.‐T., Liu, Q.‐H., Wang, Y.‐R., Wang, W.‐S., Up‐regulated miR‐192‐5p expression rescues cognitive impairment and restores neural function in mice with depression via the Fbln2‐mediated TGF‐β1 signaling pathway. FASEB J. 33, 606–618 (2019). www.fasebj.org

MiR-139-5p has an antidepressant-like effect by targeting phosphodiesterase 4D to activate the cAMP/PKA/CREB signaling pathway

MiR-184-3p in the paraventricular nucleus participates in the neurobiology of depression via regulation of the hypothalamus-pituitary-adrenal axis

Blood Mir-144-3p: a Novel Diagnostic and Therapeutic Tool for Depression

MiR-182-5p: A Novel Biomarker in the Treatment of Depression in CSDS-Induced Mice

Hippocampal miR-211-5p regulates neurogenesis and depression-like behaviors in the rat

Clinical and preclinical evaluation of miR-144-5p as a key target for major depressive disorder

Hippocampal miR-206-3p participates in the pathogenesis of depression via regulating the expression of BDNF

Role of Hippocampal miR-132-3p in Modifying the Function of Protein Phosphatase Mg2+/Mn2+-dependent 1 F in Depression

Knockdown of Mir-124 Reduces Depression-like Behavior by Targeting CREB1 and BDNF.

Mir-138 Increases Depressive-Like Behaviors by Targeting SIRT1 in Hippocampus

Knockdown of miRNA-134-5p rescues dendritic deficits by promoting AMPK-mediated mitophagy in a mouse model of depression

Mir-143-3p Modulates Depressive-Like Behaviors Via Lasp1 in the Mouse Ventral Hippocampus.

MicroRNA-451a is a candidate biomarker and therapeutic target for major depressive disorder

Mir-16 and Fluoxetine Both Reverse Autophagic and Apoptotic Change in Chronic Unpredictable Mild Stress Model Rats.

Upregulation of miR-195a inhibits brain-derived neurotrophic factor in mouse hippocampus and may contribute to depression-like behaviors induced by chronic social stress

Mir-214-3p Targets Β-Catenin to Regulate Depressive-like Behaviors Induced by Chronic Social Defeat Stress in Mice

miR-29a-5p rescues depressive-like behaviors in a CUMS-induced mouse model by facilitating microglia M2-polarization in the prefrontal cortex via TMEM33 suppression

MicroRNA-26a-3p rescues depression-like behaviors in male rats via preventing hippocampal neuronal anomalies

LncRNA NPTN-IT1-201 Ameliorates Depressive-like Behavior by Targeting miR-142-5p and Regulating Inflammation and Apoptosis via BDNF

Up‐regulated miR‐192‐5p expression rescues cognitive impairment and restores neural function in mice with depression via the Fbln2‐mediated TGF‐β1 signaling pathway

lncRNA MIR155HG Alleviates Depression-Like Behaviors in Mice by Regulating the miR-155/BDNF Axis